Background: Nyaope is a strongly addictive novel psychoactive substance that is commonly used in predominantly black townships in South Africa. The undesired behaviours of the users result in family members developing mental health challenges. Nyaope users often commit petty crimes, including stealing from families and neighbours.
Aim: The aim of this study was to quantify anxiety symptoms among family members of nyaope users in Tshwane, South Africa.
Setting: Data were collected from nine townships within Tshwane Metropolitan Municipality.
Methods: The quantitative cross-sectional survey used the General Anxiety Disorder (GAD-7) tool to quantify anxiety symptoms, and a questionnaire was used to collect sociodemographic data from a sample of 390 participants.
Results: The ages of the participants ranged from 18 years to 87 years, with a mean of 47 years. The mothers to the nyaope users were the biggest group at 35% ( = 138). The prevalence of anxiety symptoms was 73% ( = 286) of the total sample and ranged from mild (41.8, = 163), moderate (14.62, = 57) and severe (16.92%, = 66). The Pearson chi-square test identified significant associations between anxiety symptoms and the gender of the participant ( = 0.001), the age of the nyaope user and the period of nyaope use ( = 0.008). Multivariate regression model indicated gender and place of residence as a significant variable in the development of anxiety symptoms ( = 0.01).
Conclusion: Nyaope use is a risk factor for the development of anxiety for family members of nyaope users with the highest proportion reporting mild symptoms.
Contribution: There is a need to develop interventions for mental health support for families of nyaope users.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11022502 | PMC |
http://dx.doi.org/10.4102/hsag.v28i0.2083 | DOI Listing |
Front Psychiatry
January 2025
Department of Nursing, Tianjin Medical University General Hospital, Tianjin, China.
Background: This study aimed to evaluate the effectiveness of Internet-based Cognitive Behavioral Therapy (ICBT) in reducing anxiety and depressive symptoms among patients with cardiovascular diseases (CVDs) and to explore how intervention characteristics, such as module number and program duration, influence treatment outcomes.
Methods: A systematic review and meta-analysis were conducted by searching eight databases, including PubMed, Embase, and Cochrane Library, for randomized controlled trials (RCTs) published up to December 2023. Studies involving adult CVD patients with anxiety or depressive symptoms who underwent ICBT interventions were included.
Clin Psychol Sci
January 2025
Department of Psychology, University of Virginia, Charlottesville, USA.
Difficulty knowing when to switch emotion regulation (ER) strategies is theorized to be a key pathway to emotion dysregulation, but relatively few studies have empirically examined this. We applied a new order-based metric to quantify how =109 socially anxious people switched between 19 different ER strategies (or chose not to regulate at all) throughout a 5-week ecological momentary assessment study yielding 12,616 observations. We tested whether state and trait anxiety reports, and their interaction, predicted differences in ER strategy switching.
View Article and Find Full Text PDFPsychiatry Investig
January 2025
Department of Psychiatry, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Objective: This study aimed to identify the factors contributing to post-traumatic growth (PTG) among nurses who experienced patient death during the coronavirus disease-2019 (COVID-19) pandemic and to evaluate the necessity of grief support is required.
Methods: An online survey was conducted to assess the experiences of nurses at Ulsan University Hospital who lost patients during the past year of the pandemic. In total, 211 nurses were recruited.
Aust N Z J Psychiatry
February 2025
Brain and Mind Centre, The University of Sydney, Camperdown, NSW, Australia.
Globally, youth mental health services are evolving, with Australia's services presented as a leading exemplar. services were designed as enhanced primary care-based entities and were expected to collaborate with local acute, and specialist clinical and psychosocial services. The lack of large-scale health services trials necessitates understanding their impact through systematic monitoring and evaluation.
View Article and Find Full Text PDFJ Neuropsychiatry Clin Neurosci
January 2025
Department of Clinical Research, National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City (Coronel Manzo, Flores Ramos); Departments of Neurology (Amscheridam Herrera) and Internal Medicine (Zapata Arenas), General Hospital of Mexico, Mexico City; Third Medical Department and University Cancer Center, Johannes Gutenberg University, Mainz, Germany (de Jesús Naveja); Department of Psychiatry, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City (Castillejos); Faculty of Medicine, Psychiatry, and Mental Health, National Autonomous University of Mexico, Mexico City (López Sepúlveda).
Objective: The investigators compared neuropsychiatric symptoms among COVID-19 patients at hospital admission and at discharge.
Methods: Clinical data on neuropsychiatric syndromes were prospectively collected from 103 COVID-19 patients at admission and immediately before discharge. Clinical evaluations and serum biomarkers were analyzed to assess their relationship with neuropsychiatric symptoms and patient survival.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!